[1]
Rosołowski M,Kierzkiewicz M, Etiology, diagnosis and treatment of infectious esophagitis. Przeglad gastroenterologiczny. 2013; [PubMed PMID: 24868280]
[2]
Alsomali MI,Arnold MA,Frankel WL,Graham RP,Hart PA,Lam-Himlin DM,Naini BV,Voltaggio L,Arnold CA, Challenges to [PubMed PMID: 28158394]
[3]
Takahashi Y,Nagata N,Shimbo T,Nishijima T,Watanabe K,Aoki T,Sekine K,Okubo H,Watanabe K,Sakurai T,Yokoi C,Kobayakawa M,Yazaki H,Teruya K,Gatanaga H,Kikuchi Y,Mine S,Igari T,Takahashi Y,Mimori A,Oka S,Akiyama J,Uemura N, Long-Term Trends in Esophageal Candidiasis Prevalence and Associated Risk Factors with or without HIV Infection: Lessons from an Endoscopic Study of 80,219 Patients. PloS one. 2015; [PubMed PMID: 26208220]
[4]
Choi JH,Lee CG,Lim YJ,Kang HW,Lim CY,Choi JS, Prevalence and risk factors of esophageal candidiasis in healthy individuals: a single center experience in Korea. Yonsei medical journal. 2013 Jan 1; [PubMed PMID: 23225813]
[5]
Walsh TJ,Hamilton SR,Belitsos N, Esophageal candidiasis. Managing an increasingly prevalent infection. Postgraduate medicine. 1988 Aug; [PubMed PMID: 3041396]
[6]
Klotz SA, Oropharyngeal candidiasis: a new treatment option. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2006 Apr 15; [PubMed PMID: 16575740]
[7]
Pappas PG,Kauffman CA,Andes DR,Clancy CJ,Marr KA,Ostrosky-Zeichner L,Reboli AC,Schuster MG,Vazquez JA,Walsh TJ,Zaoutis TE,Sobel JD, Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2016 Feb 15; [PubMed PMID: 26679628]
[8]
Skiest DJ,Vazquez JA,Anstead GM,Graybill JR,Reynes J,Ward D,Hare R,Boparai N,Isaacs R, Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2007 Feb 15; [PubMed PMID: 17243069]
[9]
Lake DE,Kunzweiler J,Beer M,Buell DN,Islam MZ, Fluconazole versus amphotericin B in the treatment of esophageal candidiasis in cancer patients. Chemotherapy. 1996 Jul-Aug; [PubMed PMID: 8804799]
[10]
de Wet NT,Bester AJ,Viljoen JJ,Filho F,Suleiman JM,Ticona E,Llanos EA,Fisco C,Lau W,Buell D, A randomized, double blind, comparative trial of micafungin (FK463) vs. fluconazole for the treatment of oesophageal candidiasis. Alimentary pharmacology [PubMed PMID: 15801925]
[11]
Benson CA,Kaplan JE,Masur H,Pau A,Holmes KK, Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America. MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports. 2004 Dec 17; [PubMed PMID: 15841069]
[13]
Geagea A,Cellier C, Scope of drug-induced, infectious and allergic esophageal injury. Current opinion in gastroenterology. 2008 Jul; [PubMed PMID: 18622166]
[14]
Ostrosky-Zeichner L,Rex JH,Bennett J,Kullberg BJ, Deeply invasive candidiasis. Infectious disease clinics of North America. 2002 Dec; [PubMed PMID: 12512183]
[15]
Lee KJ,Choi SJ,Kim WS,Park SS,Moon JS,Ko JS, Esophageal Stricture Secondary to Candidiasis in a Child with Glycogen Storage Disease 1b. Pediatric gastroenterology, hepatology [PubMed PMID: 27066451]
[16]
Aghdam MR,Sund S, Invasive Esophageal Candidiasis with Chronic Mediastinal Abscess and Fatal Pneumomediastinum. The American journal of case reports. 2016 Jul 8; [PubMed PMID: 27389822]